$BMRN

Biomarin Pharmaceutical Inc.

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$82.131 β–Ό-2.003%

Extented Hours

VOLUME

1,404,481

DAY RANGE

83.6613 - 84.665

52 WEEK

76.02 - 100.38

Join Discuss about BMRN with like-minded investors

profile
@CarlosH-carvan #ivtrades
recently

other Put on watch $BMRN

84 Replies 9 πŸ‘ 9 πŸ”₯

profile
@dros #droscrew
recently

Grizzly Research @ResearchGrizzly We are Short Sigma Lithium Corp $SGML : Bogus Feasibility Studies & Production Delays Will Leave Investors Praying for a Buyout. Read our New Report Here: http://ooc.bz/l/123964 Upgrades 3/21: $AIZ $EMR $FL $FLT $HOG $IMO $META $NYCB $ORIC $RRC $TTE $VNO $WIX .. Downgrades 3/21: $ADC $ATNX $AWI $CYTH $GDDY $IHG $ORIC $OSH $PROF $SOLO $SU +Initiations 3/21: $ALNY $DOOO $GTLS $KIM $NTLA $PECO $PLD $RAIN $SKT $SPG $VRTX $VTYX .. -Initiations 3/21: $BMRN $FR $HPP $IONS $MAC $SLG $VNO

75 Replies 8 πŸ‘ 13 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

1041 $BMRN Mar23 100 Puts $2.85 (CboeTheo=2.75) ASKSIDE AMEX IV=45.4% +9.2 BZX 10 x $2.55 - $3.00 x 34 EDGX FLOOR - OPENING Pre-Earnings Vol=1131, OI=116

64 Replies 6 πŸ‘ 6 πŸ”₯

profile
@HeyShoe #droscrew
recently

RECAP 11/19 Chatter: $ORCL + DOD Cloud $BA - SlowS Dreamliner Production $BA - House 787 Oversight review $BMRN + Voxzogo approval $MNTV - $ZEN t/o DOA $BKKT + Ether available $DIS + Hulu bundle $RIVN - battery test Qs $V + CFO expects $AMZN resolution $XPO + Assets Sale

84 Replies 15 πŸ‘ 11 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, October 28, 2021 Futures Up/Down % Last Dow 54.00 0.15% 35,443 S&P 500 11.25 0.26% 4,556 Nasdaq 74.50 0.47% 15.662 U.S. futures are looking at a rebound after a late day swoon erased record gains for stocks, as markets again await another earnings barrage, with yesterday and today the two busiest days of the quarter. Drama out of Washington D.C. also adding to the volatility as investors remain hopeful on a spending bill. As for Wednesday, a midday all-time high for the Nasdaq 100 was marred by a late day sell-off in U.S. stocks, as the S&P 500 and Dow each retreated from records set just the previous day, led by weakness in energy stocks as oil prices tumbled from 7-year highs and long-dated Treasury yields also slumped, with the 30-year falling as much as 10bps below 2%. Corporate earnings have generally been better-than-expected, but constant reminders about rising costs, supply-chain issues, and labor shortages on conference calls brings into question the strength of markets going forward. Couple that with expectations for the Fed to begin its asset tapering plans in November and chances of interest rate hikes in mid-2022 to help prevent inflation getting further out of hand remains a market concern. Shares of Dow components McDonald’s, Coca-Cola and Microsoft rallied behind strong earnings. In fact, the Nasdaq outperformed behind large cap winners (TSLA, GOOGL MSFT, AMZN), though breadth was decisively negative and SmallCaps plunged with the Russell 200 falling nearly 2%. President Biden’s infrastructure and social-spending plans still remain β€œup-in-the-air” which also adds uncertainty. In Asian markets, The Nikkei Index fell about 1% to 28,820, the Shanghai Index slipped -1.23% to 3.518 and the Hang Seng Index dipped about -0.25% to 25,555. In Europe, the German DAX is down -0.15% at 15,680, while the FTSE 100 is also down roughly -0.2% at 7,240. Market Closing Prices Yesterday The S&P 500 Index dropped -23.11 points, or 0.51%, to 4,551.68 The Dow Jones Industrial Average fell -266.19 points, or 0.74%, to 35,490.69 The Nasdaq Composite little changed, or 0.00%, to 15,235.84 The Russell 2000 Index declined -43.58 points, or 1.90% to 2,252.49 Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 290K 8:30 AM EST Continuing Claims…est. 2.415M 8:30 AM ET Gross Domestic Product (GDP) for Q3-A…est. 2.7% (down from prior) 8:30 AM ET GDP Consumer Spending for Q3-A…prior month 12.0% 8:30 AM ET GDP Price Deflator for Q3…est. 5.5% 8:30 AM ET Core-PCE Prices Advance for Q3…est. 4.5% 10:00 AM ET Pending Home Sales MoM for September…est. 0% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for October 1:00 PM ET U.S. to sell $62 bln 7-year notes Earnings Calendar: Earnings Before the Open: AB, ABMD, ADS, AEP, AGCO, ALNY, AMT, AOS, ATI, BAX, BC, BSIG, BTU, CARR, CAR, CBRE, CBZ, CFR, CG, CMCO, CMCSA, CMS, CNX, COLB, CONE, COOP, COR, CWT, DBD, EME, EXP, FCN, GPI, GVA, HBAN, HSY, IBP, ICE, ITW, KBR, KDP, KEX, LECO, LH, LKQ, MA, MCO, MDD, MO, MRK, NEM, NLSN, NOC, OSK, OSIS, OSTK, PBF, RGEN, RLGY, RS, SAH, SAIA, SNDR, SWI, SWK, TAP, TFX, TPX, TREE, TW, TXT, VC, VLY, WEX, WST, XEL, YUM Earnings After the Close: AAPL, ABCB, ACHC, AGL, AMZN, ASPN, ATEN, ATR, AVT, AX, BIO, BY, CDNA, CHE, COHU, COLM, CPT, CUZ, CWST, DECK, DVA, DXCM, EB, EMN, FISI, FTDR, FTV, GILD, HIG, HUBG, LOPE, LPLA, LTC, NGRC, MHK, MMSI, MPWR, MSTR, NATI, NXGN, PEB, POWI, PSB, PTCT, QUMU, RMD, RSG, SBCF, SBUX, SGEN, SKX, SKYW, SM, SPNE, SSNC, SYK, TEX, TXRH, VCRA, VRSN, WDC, WRAP, WRE, X, ZEN Macro Up/Down Last Nymex -1.61 81.05 Brent -1.37 83.21 Gold -2.10 1,801.20 EUR/USD -0.0006 1.1598 JPY/USD -0.23 113.57 10-Year Note +0.012 1.541% Sector News Breakdown Consumer eBay Inc. (EBAY) 3Q adj EPS $0.90 vs est. $0.89 on revs $2.5B vs est. $2.46B; guides 4Q adj EPS $0.72-0.76 vs est. $1.00, sees 4Q revs $2.57-2.62B vs est. $2.65B; raising estimated FY share buyback from $5.0B to $7.0B Ford Motor (F) announces resumption of stock dividend in 4q; 3Q adj EPS $0.51 vs est. $0.27 on revs $35.7B vs est. $32.5B; expects cash flow over current planning period to be more than sufficient to fund growth, announces resumption of regular stock dividend in 4Q; no changes to FY adj FCF guide of $4.0-5.0B Boot Barn (BOOT) Q2 EPS $1.25 vs est. $0.93 on revenue $312.7M (+67.1% vs 2Q19) vs est. $291M, same-store sales +61.7% YoY, +53.6% vs 2019; sees new unit growth 10% in FY22; named Jim Watkins as CFO with current CFO Greg Hackman continuing as VP and COO Churchill Downs (CHDN) 3Q EPS $1.57 vs est. $1.47 on revs $393Mm vs est. $406.8Mm Fresh Del Monte Produce Inc. (FDP) said it is raising prices on bananas, pineapples and fresh-cut fruit in response to unprecedented market conditions and inflationary pressures being felt across all industries iRobot (IRBT) Q3 EPS $1.67 vs. est. $0.70; Q3 revs $440.7M vs. est. $417.04M; cuts FY21 non-GAAP EPS view to $1.15-$1.74 from $2.25-$3.15 (est. $2.70) and lowers FY21 revenue view to $1.56B-$1.59B from $1.55B-$1.62B (est. $1.58B) Noodles (NDLS) Q3 adj EPS 12c vs est. 9c on in-line revenue $125.1M with digital sales 52% of total revs; system-wide comp sales +16.3% vs est. +14.3%, avg unit volume $1.38M, +16% YoY; now sees 7-9 new restaurants in 2021, down from prior outlook for 10-15; anticipates system-wide unit growth of at least 8% next year O’Reilly Auto (ORLY) Q3 EPS $8.07 vs. est. $7.18; Q3 sales $3.48B vs. est. $3.3B; gross profit margin 52.3% vs. 52.4% y/y; raises year rev outlook to $12.9B-$13.2B from prior $12.3B-$12.6B (est. $12.73B) Sleep Number (SNBR) 3Q EPS $2.22 vs est. $1.44 on revs $640Mm vs est. $587.1Mm; sees FY EPS $7.25 vs est. $7.15; Spirit Airlines (SAVE) Q3 adj EPS ($0.69) was a narrower loss than est. ($1.02) on in-line revs $922.6M; load factor 77.6%, capacity +3.5% vs 3Q19; is slowing the pace to push back to full fleet utilization, expects to produce 53B-55B available seat miles in 2022 VICI Properties (VICI) 3Q adj FFO/shr $0.45 on revs $375.7Mm; guides FY adj FFO/shr $1.7901.80 vs est. $1.84 Wyndham Hotels (WH) 3Q EPS $1.09 vs est. $0.91 on net revs $463Mm vs est. $463Mm; guides FY RevPAR growth about 43%, sees fee-related and other revs $1.21-1.23B; guides FY adj EPS $2.93-3.03 vs est. $2.69 Yum China (YUMC) Q3 adj EPS $0.22 vs. est. $0.31; Q3 revs $2.55B vs. est. $2.51B; qtrly total system sales increased 1% year over year, with increases of 1% at both KFC and Pizza Hut, excluding f/x; increasing gross new stores target to over 1,700 in 2021; expect that covid-19, especially the delta variant outbreaks, will continue to affect consumer behavior and impact our same-store sales recovery. Solo Brands, Inc. (DTC) prices 12.9M share IPO at $17.00 per share Scientific Games Corp (SGMS) announces sale of lottery business to Brookfield business partners for $6.05 billion; deal consisting of $5.825 bln in cash & an earn-out of up to $225 mln based on achievement of certain ebitda targets in 2022 & 2023 Energy, Industrials & Materials Allison Transmission (ALSN) 3Q EPS $0.89 vs est. $0.90 on revs $567Mm vs est. $584Mm; guides FY sales $2.325-2.4B vs est. $2.36B Flowserve Corp. (FLS) 3Q adj EPS $0.29 vs est. $0.40 on revs $866.1Mm vs est. $899Mm; guides FY revs down 2-4% vs est. -2.3%, sees FY EPS $1.45-1.65 (was $1.40-1.45) vs est. $1.58, sees CAPEX $70-80Mm vs prior $65Mm Kraton (KRA) Q3 adj EPS $0.98 vs. est. $0.79; Q3 revs $526.9M vs. est. $459.1M; Polymer segment operating income of $43.8 million, compared to an operating loss of $5.1 million YoY; Chemical segment operating income of $35.7M, compared to an operating loss of $401.7M YoY Sunnova Energy (NOVA) Q3 EPS ($0.25) vs est. ($0.13) on revenue $68.9M vs est. $67.4M; reaffirmed FY21 view for adj EBITDA $80M-$85M, customer additions 55k-58k; set FY22 guidance for adj EBITDA $117M-$137M, customer additions 83k-87k Tronox Holdings (TROX) Q3 adj EPS $0.72 vs. est. $0.64; Q3 revs rose 29% to $870M vs. est. $905.3M United Rentals (URI) 3Q adj EPS $6.58 vs est. $6.80 on revs $2.6B vs est. $2.58B; guides FY revs $9.6-9.75B vs est. $9.6B, sees FY adj EBITDA $4.325-4.4B vs est. 4.3B Financials Aflac (AFL) Q3 adj EPS $1.53 vs. est. $1.32; Q3 revs $5.2B vs. est. $5.34B; in yen terms, Aflac Japan’s net premium income was Β₯323.1 bln for quarter, or 4.0% lower than a year ago AvalonBay (AVB) Q3 core FFO $2.06 vs est. 1.97, EPS $0.56 vs est. $0.77, same-store sales +1.2%; sees Q4 core FFO $2.19-$2.29 vs est. $2.11, raised FY core FFO view to $8.18-$8.28 from $7.92-$8.12 CyrusOne Inc. (CONE) 3Q adj FFO/shr $1.02 vs est. $0.99 on revs $304.1Mm vs est. $290.4Mm; guides FY revs $1.18-1.2B vs est. $1.17B Invitation Homes (INVH) Q3 core FFO 38c/shr vs est. 36c, EPS 12c vs est. 10c, revenue $510M vs est. $497.8M; same-store NOI +11.9% YoY on same-store revs +7.9%; raised FY21 core EPS view to $1.49 at midpoint from $1.44, adj FFO ro $1.28 at midpoint from $1.24 Lending Club (LC) Q3 EPS $0.26 vs est. $0.03 on revenue $246.2M vs est. $221.2M; sees Q4 revs $240M-$250M vs est. $235.7M, loan originations $2.8-$3B; raised FY view for revenue to $796M-$806M from $750M-$780M Raymond James (RJF) Q4 EPS $2.06 vs. est. $1.71; Q4 revs $2.7B vs. est. $2.54B; quarter-end records for client assets under administration of $1.18 trillion, financial assets under management of $191.9B, and net loans at Raymond James Bank of $25B The SEC asked at least one asset manager not to proceed with plans for a leveraged bitcoin exchange-traded fund, according to a person familiar with the matter. The SEC indicated it wants to limit new bitcoin-related products to those that provide unleveraged exposure to bitcoin futures contracts, such as the ProShares Bitcoin Strategy exchange-traded fund, which was launched last week, the person said. https://on.wsj.com/3GvG2qg Healthcare Align Technology (ALGN) 3Q adj EPS $2.87 vs est. $2.60 on revs $1.02B vs est. $978Mm; guides FY revs $3.9-3.95B vs est. $3.94B; says clinical study validates benefits of the Itero Element 5D imaging system Alnylam (ALNY) reports positive topline 18-month results from Helios-a phase 3 study of Vutrisiran in patients with HATTR amyloidosis with polyneuropathy BioMarin (BMRN) Q3 GAAP EPS loss (-$0.20) vs. est. loss (-$0.25); Q3 revs $408.7M vs. est. $435.32M; Lower Kuvan product revenues primarily due to generic competition due to the loss of exclusivity in the U.S.; Lower Aldurazyme product revenues due to timing of product fulfillment to Genzyme Edwards LifeSciences (EW) Q3 EPS $0.54 vs. est. $0.53; Q3 revs $1.3B vs. est. $1.32B; sees FY21 adjusted EPS at high end of $2.07-$2.27 (est. $2.26) and reaffirms FY21 revenue view $5.2B-$5.4B (est. $5.32B); TAVR sales grew 15%; underlying 14%; U.S. TAVR sales grew 12%; OUS approximately 20% Encompass Health (EHC) Q3 adj EPS $1.03 vs. est. $1.06; Q3 revs $1.28B vs. est. $1.31B; cuts FY21 adj EPS view to $4.23-$4.38 from $4.32-$4.47 and lowers FY21 revenue view to $5.08B-$5.13B from $5.1B-$5.25B (est. $5.18B) Molina Healthcare (MOH) Q3 adj EPS $2.83 vs. est. $2.79; Q3 revs $7.04B vs. est. $6.79B; backs FY21 EPS view of no less than $13.25 vs. est. $13.38 and backs FY21 revenue view of no less than $27.5B vs. est. $26.97B; consolidated MCR for Q3 was 88.9%, compared to 85.9% in the third quarter of 2020 Teladoc (TDOC) Q3 EPS loss (-$0.53) vs. est. loss (-$0.65); Q3 revs $521.66M vs. est. $516.6M; Q3 visits topped 3.9M, 37% higher than Q3 2020; sees Q4 EPS loss (73c)-(53c) vs. est. loss (69c); sees Q4 revs $536M-$546M vs. est. $539.74M; sees Q4 total visits 3.9M-4.1M

119 Replies 15 πŸ‘ 11 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

SCAN RESULTS - BULLISH BOTTOMS $DISCA, $CHGG, $STNE, $ATVI, $PSX, $AZEK, $ETSY, $FTCH, $POSH, $UAA, $SNAP, $PFGC, $BMRN, $CAT, $BIGC, $AVLR, $RSX, $BKR, $COUP, $STNE, $LI, $LESL, $BMBL, $PTON, $IOVA, $RUBY TOPS $ATVI, $FTCH, $FVRR, $IFT, $SBH, $SONY, $YUM, $CVS, $NVST, $CAT, $SYK, $TDC, $TWLO, $RSX, $AMZN, $ALXN BEARISH $BK, $ELS, $KMX, $MCK, $NIO, $WFC, $NVDA, $TLT, $VALE, $INFY

76 Replies 6 πŸ‘ 7 πŸ”₯

profile
@hidalgjo #ivtrades
recently

Looking to short some $BMRN here. Placing a stop loss at $81.40 and looking to drop till mid $73s

124 Replies 6 πŸ‘ 7 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$BMRN sweep Oct15 90C

149 Replies 13 πŸ‘ 15 πŸ”₯

profile
@thegiz18 #ivtrades
recently

Lot of interesting earnings after close > @thegiz18 said: After close earnings today include $BYND, $ADSK, $BMRN, $CZR, $CVNA, $DELL, $DASH, $DVAX, $ETSY, $FTCH, $FSLR, $FSR, $GRPN, $HPQ, $NKLA, $QRTEA, $REGI, $RKT, $CRM, $SHAK, $STOR, $SFM, $RUN, $SPCE, $WDAY, $WW. $ZS that is a lot of stocks talked about on this group

104 Replies 7 πŸ‘ 7 πŸ”₯

profile
@thegiz18 #ivtrades
recently

After close earnings today include $BYND, $ADSK, $BMRN, $CZR, $CVNA, $DELL, $DASH, $DVAX, $ETSY, $FTCH, $FSLR, $FSR, $GRPN, $HPQ, $NKLA, $QRTEA, $REGI, $RKT, $CRM, $SHAK, $STOR, $SFM, $RUN, $SPCE, $WDAY, $WW. $ZS that is a lot of stocks talked about on this group

57 Replies 8 πŸ‘ 11 πŸ”₯

profile
@RedSunCap #droscrew
recently

1500 $BMRN Apr 2021 100 Calls trade $4.893

40 Replies 8 πŸ‘ 6 πŸ”₯

profile
@RedSunCap #droscrew
recently

1500 $BMRN Apr 2021 100 Calls trade $4.893

135 Replies 9 πŸ‘ 15 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

1500 $BMRN Apr 2021 100 Calls trade $4.893 (FT Theo=4.20) ASKSIDE [ISE] 11:24:47 IV=46.4% +9.1 AUCTION - OPENING Vol=1601, OI=278,

116 Replies 8 πŸ‘ 13 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

good example was yday's $BMRN !

62 Replies 15 πŸ‘ 11 πŸ”₯

MB
@MB-2020 #ivtrades
recently

Is that worth buying $BMRN Jan 22 calls?

84 Replies 12 πŸ‘ 15 πŸ”₯

SJ
@sj2343 #StockTraders.NET
recently

what do you guys think of BMRN long?

74 Replies 10 πŸ‘ 13 πŸ”₯

profile
@thegiz18 #ivtrades
recently

$BMRN got kicked in the head by the FDA, down 35%

116 Replies 15 πŸ‘ 15 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

wow... $BMRN at 75 hahaha

117 Replies 8 πŸ‘ 7 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

$BMRN about to crack 78 Jesus

49 Replies 14 πŸ‘ 10 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

$BMRN with the 80 crack... 75 EOD? Jesus

129 Replies 14 πŸ‘ 9 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$BMRN looks like 76`s is coming

119 Replies 6 πŸ‘ 13 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

$BMRN too.. 15 points πŸ₯΄

140 Replies 11 πŸ‘ 9 πŸ”₯

SJ
@sj2343 #StockTraders.NET
recently

long $BMRN 81.62

117 Replies 6 πŸ‘ 15 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

$BMRN really about to crack 80 soon. wow wow wow lol

46 Replies 12 πŸ‘ 9 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

😭😭 I full covered at 89... gotta learn to have some patience lol > @FillTheGapToZero said: all out BMRN at 89.30. glad with profits. break of 88 and I’m in again to touch 85

127 Replies 10 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$BMRN could re-test 80`s easily

129 Replies 14 πŸ‘ 7 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

$BMRN straight up bleeding... why didn’t I enter 88 like I said I would 😭😭

64 Replies 12 πŸ‘ 11 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

$BMRN wow, covered too early lol

93 Replies 12 πŸ‘ 7 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

all out BMRN at 89.30. glad with profits. break of 88 and I’m in again to touch 85

92 Replies 9 πŸ‘ 7 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

$BMRN nice little short from 94-95

72 Replies 14 πŸ‘ 7 πŸ”₯

profile
@thegiz18 #ivtrades
recently

Earnings of interest after the close today include $BYND, $ATVI, $TWLO, $ENPH, $WYNN, $BMRN, $PRU, $KTOS, $ALL, $OI, $ANDE, $NKLA

133 Replies 11 πŸ‘ 14 πŸ”₯

TR
@TraderJack #ivtrades
recently

Still in $BMRN, $NBIX, $AZN, $NXTC, $EBS, and $PFE. It is ok for them down today

128 Replies 12 πŸ‘ 6 πŸ”₯

profile
@RedSunCap #droscrew
recently

still sitting in OCT 120s in BMRN

50 Replies 15 πŸ‘ 10 πŸ”₯

profile
@dros #droscrew
recently

$BMRN breaking out

130 Replies 15 πŸ‘ 14 πŸ”₯

TR
@TraderJack #ivtrades
recently

Your guys can buy $AZN, $BMRN, $ALNY, $DVAX, $EBS, and $NBIX, these are the potential contractors for my vaccine. However, be careful that some of them will drop hard if they does not get my vaccine contracts...who will get the final deal is my insider information...secret..

110 Replies 6 πŸ‘ 14 πŸ”₯

TR
@TraderJack #ivtrades
recently

$NBIX and $BMRN already has high earning growth,

47 Replies 12 πŸ‘ 13 πŸ”₯

TR
@TraderJack #ivtrades
recently

Added $EBS, $NBIX and $BMRN recently to my bio positions

95 Replies 7 πŸ‘ 7 πŸ”₯

TR
@TraderJack #ivtrades
recently

Added $BMRN at $120 and $FCX at $12.80 to my portfolio for long term holdings this morning

41 Replies 8 πŸ‘ 7 πŸ”₯

Key Metrics

Market Cap

15.82 B

Beta

0.62

Avg. Volume

1.53 M

Shares Outstanding

188.68 M

Yield

0%

Public Float

0

Next Earnings Date

2024-05-01

Next Dividend Date

Company Information

biomarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. we remain steadfast to our original missionβ€”to bring new treatments to market that will make a big impact on small patient populations. these patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. these conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options and are usually ignored. time is critical to patients with rare diseases, and we strive to quickly develop important therapies for them. the efficiency and speed of our research, development, manufacturing, and commercial efforts is at the heart of our ability to urgently deliver therapies. our track record of developing and commercializing new treatment

CEO: Jean-Jacques Bienaime

Website:

HQ: 105 Digital Dr Novato, 94949-8703 California

Related News